healthcare News
Zevra Therapeutics Shares Surge on $50M Asset Sale
Rare disease specialist becomes debt-free after disposing of SDX portfolio and resolving litigation
Alto Neuroscience watches as FY2025 EPS misses, cash supports 2026 readouts
Signal reports FY2025 EPS of -$2.19 vs -$0.64 est; $177M cash runway into 2028 with four data catalysts
MBX Biosciences falls 3.4% on wider loss despite earnings beat
Clinical-stage biotech reports strong pipeline progress but R&D spending drives net loss to $87M
Century Therapeutics narrows loss despite 8% post-earnings drop
BMS partnership drives revenue surge to $109.2M as cash runway extends to 2029
Nektar beats estimates but shares fall 4% on annual decline
Revenue drops 25% YoY following Huntsville facility sale, offset by strong clinical data and February financing
Lyell begins Phase 3 CAR-T trial with 93% response rate data
Head-to-head study positions ronde-cel against approved therapies as biotech targets BLA submission in 2027
Allogene earnings beat fails to halt 6% post-market decline
Investors take profits after 60% February rally, despite extended cash runway and positive EPS surprise
Erasca surges on Q4 beat, financing, clinical data
$259M capital raise extends runway to 2028 as ERAS-0015 shows promise in RAS-mutant tumors